The role of alemtuzumab in the treatment of chronic lymphocytic leukemia

Clive S. Zent

doi:10.1080/10428190701809206

The role of alemtuzumab in the treatment of chronic lymphocytic leukemia

Clive S. Zent

Hematology

Research output: Contribution to journal › Comment/debate › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	175-176
Number of pages	2
Journal	Leukemia and Lymphoma
Volume	49
Issue number	2
DOIs	https://doi.org/10.1080/10428190701809206
State	Published - Feb 2008

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1080/10428190701809206

Cite this

@article{43f4e7de5d264b0ea2809562b2c8b0b7,

title = "The role of alemtuzumab in the treatment of chronic lymphocytic leukemia",

author = "Zent, {Clive S.}",

year = "2008",

month = feb,

doi = "10.1080/10428190701809206",

language = "English (US)",

volume = "49",

pages = "175--176",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "2",

}

TY - JOUR

T1 - The role of alemtuzumab in the treatment of chronic lymphocytic leukemia

AU - Zent, Clive S.

PY - 2008/2

Y1 - 2008/2

UR - http://www.scopus.com/inward/record.url?scp=38849161398&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38849161398&partnerID=8YFLogxK

U2 - 10.1080/10428190701809206

DO - 10.1080/10428190701809206

M3 - Comment/debate

C2 - 18231900

AN - SCOPUS:38849161398

SN - 1042-8194

VL - 49

SP - 175

EP - 176

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 2

ER -

The role of alemtuzumab in the treatment of chronic lymphocytic leukemia

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this